$9 billion
Punitive damages faced by Takeda Pharmaceutical Co. and its marketing partner Eli Lilly & Co. after a U.S. jury decided that the drug makers hid the cancer risks of their Actos diabetes drug.
(Source: Wall Street Journal)
EWM Number of the Day: 4/9/2014
